
Loading, please wait...

Loading, please wait...

Inflammatory bone defects significantly impact human health, especially when traditional stem cell therapies struggle against high oxidative stress. Recent breakthroughs in chiral nanozymes bone regeneration highlight the potential of metal-organic framework (MOF) nanozymes. Researchers inspired by deep-sea lobster hemocyanin have developed bionic Cu-Phe (D/L) nanozymes that effectively regulate the intracellular antioxidant defense system.
The study utilized a chiral engineering strategy to prepare Cu-Phe nanozymes using right-handed (D) and left-handed (L) phenylalanine ligands. Furthermore, the researchers observed that the Cu-Phe (L) variant clears reactive oxygen species (ROS) with remarkable efficiency. Consequently, this clearing of ROS protects cellular functionality and facilitates a shift in macrophage phenotype. Therefore, these nanozymes create a favorable environment for stem cell growth and tissue repair.
Moreover, the bionic nanozymes mimic natural superoxide dismutase (SOD) and catalase (CAT) activities. By reshaping the oxidative stress microenvironment, the Cu-Phe (L) nanozymes enhance osteoimmunomodulation. Specifically, they promote the differentiation of stem cells into bone-forming cells. Thus, this technology provides a rational roadmap for treating complex inflammatory bone defects using biomimetic materials.
Chiral nanozymes modulate oxidative stress by mimicking natural enzymes. Specifically, the left-handed Cu-Phe (L) variant effectively removes harmful reactive oxygen species, thereby allowing stem cells to differentiate into bone tissue more efficiently.
These nanozymes offer a targeted approach to treating bone defects characterized by chronic inflammation. Furthermore, they provide a more stable and effective alternative to traditional therapies in high-stress microenvironments.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers developed chiral Cu-Phe nanozymes that mimic lobster hemocyanin to clear ROS and promote osteogenic differentiation in inflammatory bone defects...
8 months ago

Novel diimide and hydrazone scaffolds, particularly compound #C4, synergistically reactivate latent HIV-1 when combined with JQ1 or PKC activators. Demonstrating donor-matched proviral transcription ex vivo and non-canonical signaling, these findings advance shock and kill strategies toward reservoir eradication.
Today

A cross-sectional study reveals that maternal RSV vaccination coverage reached only 43.7% in Argentina, with maternal vaccine knowledge being the sole independent predictor of uptake. Clinicians play a crucial role in eliminating informational and structural barriers to optimize infant health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday